Judith Love

Judith Love has led Novartis’s Asia Pacific, Middle East and Africa region from Singapore since July 2024, having joined the Swiss drugmaker from Roche in 2012. In July 2026, she signed an agreement with South Korea’s health ministry underpinning a planned 140 billion won (about $95 million) investment in radioligand cancer therapies. The initiative includes a local manufacturing facility and cold-chain logistics network, alongside a target to expand the number of hospitals offering the treatment from 10 to 30—linking Novartis’s production expansion to wider patient access.